Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aura Biosciences, Inc.AURA · Entity 5142 | Chief People Officer | September 01, 2026 | September 01, 2026 |
| Third Harmonic Bio, Inc.THRD · Entity 76517 | CHIEF ADMINISTRATIVE OFFICER | January 15, 2025 | January 17, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aura Biosciences, Inc.
Report date September 01, 2026 · Filed September 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 107,611 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Grant · Acquired 107,611 · Balance 107,611 F1: These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.43 · Expires 2036-09-01 | Direct | 212,389 |
Reported balance
After 2026-09-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-01 · Grant · Acquired 212,389 · Balance 212,389 F2: The option shall vest as follows: 25% of the options vest on August 12, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027.
F2: The option shall vest as follows: 25% of the options vest on August 12, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.
Third Harmonic Bio, Inc.
Report date January 15, 2025 · Filed January 17, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.00 · Expires 2035-01-14 | Direct | 100,000 |
Reported balance
After 2025-01-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-01-15 · Grant · Acquired 100,000 · Balance 100,000 F1: The equity awards of the Reporting Person in this Form 4 were approved on December 17, 2024 by the board of directors as part of the annual refresh equity grant process of the registrant with an effective grant date of January 15, 2025. F2: The option vests over a four-year period: 2.0833% shall vest on February 15, 2025, after which 2.0833% of the total shares vest monthly, subject to contioued service through each vestiog date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 12,500 |
Reported balance
After 2025-01-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-01-15 · Grant · Acquired 12,500 · Balance 12,500 F3: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F1: The equity awards of the Reporting Person in this Form 4 were approved on December 17, 2024 by the board of directors as part of the annual refresh equity grant process of the registrant with an effective grant date of January 15, 2025. F4: The RSU vests over a four-year period: 1/4 on Febuary 15, 2026, after which 1/4 of the total shares vest annually, subject to contioued service through each vestiog date. |
Filing footnotes · ownership attribution and instrument terms
F1: The equity awards of the Reporting Person in this Form 4 were approved on December 17, 2024 by the board of directors as part of the annual refresh equity grant process of the registrant with an effective grant date of January 15, 2025.
F2: The option vests over a four-year period: 2.0833% shall vest on February 15, 2025, after which 2.0833% of the total shares vest monthly, subject to contioued service through each vestiog date.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F4: The RSU vests over a four-year period: 1/4 on Febuary 15, 2026, after which 1/4 of the total shares vest annually, subject to contioued service through each vestiog date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 1, 2026 21:28 UTC | Aura Biosciences, Inc. AURA · Entity 5142 | GrantStock Option (Right to Buy) · Derivative | 212,389 | $0.00 Strike: $7.43 | $0.00 |
DisclosureSEC source: 0001946505-26-000009 · form4-09012026_090914.xml · derivative · entry 2 Person Julie · CIK 0001946505 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,389 Underlying: Common Stock · 212,389 shares Expires 2036-09-01 F2 · derivative.exercise_date: The option shall vest as follows: 25% of the options vest on August 12, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 21:28 UTC | Aura Biosciences, Inc. AURA · Entity 5142 | GrantCommon Stock | 107,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001946505-26-000009 · form4-09012026_090914.xml · nonDerivative · entry 1 Person Julie · CIK 0001946505 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,611 F1 · shares: These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 18:07 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | GrantRestricted Stock Unit · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001722 · form4-01172025_110143.xml · derivative · entry 2 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F1 · kind: The equity awards of the Reporting Person in this Form 4 were approved on December 17, 2024 by the board of directors as part of the annual refresh equity grant process of the registrant with an effective grant date of January 15, 2025. F4 · derivative.exercise_date: The RSU vests over a four-year period: 1/4 on Febuary 15, 2026, after which 1/4 of the total shares vest annually, subject to contioued service through each vestiog date. F4 · derivative.expiration_date: The RSU vests over a four-year period: 1/4 on Febuary 15, 2026, after which 1/4 of the total shares vest annually, subject to contioued service through each vestiog date. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 18:07 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001722 · form4-01172025_110143.xml · derivative · entry 1 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-01-14 F1 · kind: The equity awards of the Reporting Person in this Form 4 were approved on December 17, 2024 by the board of directors as part of the annual refresh equity grant process of the registrant with an effective grant date of January 15, 2025. F2 · derivative.exercise_date: The option vests over a four-year period: 2.0833% shall vest on February 15, 2025, after which 2.0833% of the total shares vest monthly, subject to contioued service through each vestiog date. Read SEC document |
| September 19, 2024 Filed Sep 20, 2024 17:35 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | Exercise / conversionEmployee Option Grant (right to buy) · Derivative | 9,497 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0001415889-24-023787 · form4-09202024_090923.xml · derivative · entry 6 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 155,962 Underlying: Common Stock · 9,497 shares Expires 2032-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the total shares vest on June 20, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| September 19, 2024 Filed Sep 20, 2024 17:35 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | SaleCommon Stock | 9,497 | $14.29 | $135,684.59 |
DisclosureSEC source: 0001415889-24-023787 · form4-09202024_090923.xml · nonDerivative · entry 4 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated March 27, 2024. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.53 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 19, 2024 Filed Sep 20, 2024 17:35 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | Exercise / conversionCommon Stock | 9,497 | $4.20 | $39,887.40 |
DisclosureSEC source: 0001415889-24-023787 · form4-09202024_090923.xml · nonDerivative · entry 3 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 17:35 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | Exercise / conversionEmployee Option Grant (right to buy) · Derivative | 503 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0001415889-24-023787 · form4-09202024_090923.xml · derivative · entry 5 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 165,459 Underlying: Common Stock · 503 shares Expires 2032-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the total shares vest on June 20, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 17:35 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | SaleCommon Stock | 503 | $14.00 | $7,042.00 |
DisclosureSEC source: 0001415889-24-023787 · form4-09202024_090923.xml · nonDerivative · entry 2 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated March 27, 2024. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 17:35 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | Exercise / conversionCommon Stock | 503 | $4.20 | $2,112.60 |
DisclosureSEC source: 0001415889-24-023787 · form4-09202024_090923.xml · nonDerivative · entry 1 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2024 Filed Jun 28, 2024 16:51 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | Exercise / conversionEmployee Option Grant (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0001415889-24-018457 · form4-06282024_080608.xml · derivative · entry 3 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 165,962 Underlying: Common Stock · 10,000 shares Expires 2032-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the total shares vest on June 20, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| June 26, 2024 Filed Jun 28, 2024 16:51 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | SaleCommon Stock | 10,000 | $12.46 | $124,569.00 |
DisclosureSEC source: 0001415889-24-018457 · form4-06282024_080608.xml · nonDerivative · entry 2 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated March 27, 2024. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.90 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 26, 2024 Filed Jun 28, 2024 16:51 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | Exercise / conversionCommon Stock | 10,000 | $4.20 | $42,000.00 |
DisclosureSEC source: 0001415889-24-018457 · form4-06282024_080608.xml · nonDerivative · entry 1 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 17:21 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | Exercise / conversionEmployee Option Grant (right to buy) · Derivative | 1,107 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0001415889-24-010512 · form4-04082024_090451.xml · derivative · entry 3 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,962 Underlying: Common Stock · 1,107 shares Expires 2032-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the total shares vest on March 7, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 17:21 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | SaleCommon Stock | 1,107 | $10.00 | $11,070.00 |
DisclosureSEC source: 0001415889-24-010512 · form4-04082024_090451.xml · nonDerivative · entry 2 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated May 15, 2023. Read SEC document |
| April 04, 2024 Filed Apr 8, 2024 17:21 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | Exercise / conversionCommon Stock | 1,107 | $4.20 | $4,649.40 |
DisclosureSEC source: 0001415889-24-010512 · form4-04082024_090451.xml · nonDerivative · entry 1 Person Julie · CIK 0001946505 · CHIEF ADMINISTRATIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 16:07 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | GrantEmployee Option Grant (right to buy) · Derivative | 116,000 | $0.00 Strike: $10.89 | $0.00 |
DisclosureSEC source: 0001209191-24-001235 · doc4.xml · derivative · entry 1 Person Julie · CIK 0001946505 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,000 Underlying: Common Stock · 116,000 shares Expires 2034-01-04 F1 · derivative.exercise_date: The option vests over a four-year period: 1/48th on February 5, 2024, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 16:04 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | Exercise / conversionEmployee Option Grant (right to buy) · Derivative | 12,863 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0001209191-23-057714 · doc4.xml · derivative · entry 3 Person Julie · CIK 0001946505 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,137 Underlying: Common Stock · 12,863 shares Expires 2032-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests over a four-year period: 1/48th on November 25, 2022, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 16:04 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | SaleCommon Stock | 12,863 | $10.30 | $132,483.75 |
DisclosureSEC source: 0001209191-23-057714 · doc4.xml · nonDerivative · entry 2 Person Julie · CIK 0001946505 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated May 15, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 16:04 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | Exercise / conversionCommon Stock | 12,863 | $4.20 | $54,024.60 |
DisclosureSEC source: 0001209191-23-057714 · doc4.xml · nonDerivative · entry 1 Person Julie · CIK 0001946505 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 17:01 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | GrantEmployee Stock Option (right to buy) · Derivative | 119,000 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0001209191-23-017236 · doc4.xml · derivative · entry 5 Person Julie · CIK 0001946505 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,000 Underlying: Common Stock · 119,000 shares Expires 2033-03-05 F4 · derivative.exercise_date: The option vests over a four-year period: 1/48th on April 6, 2023, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 17:01 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | GrantEmployee Stock Option (right to buy) · Derivative | 80,000 | Not disclosed Strike: $4.20 | Not disclosed |
DisclosureSEC source: 0001209191-23-017236 · doc4.xml · derivative · entry 4 Person Julie · CIK 0001946505 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2032-10-24 F1 · kind: The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options. F1 · price: The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options. F3 · derivative.exercise_date: The option vests over a four-year period: 1/48th on November 25, 2022, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 17:01 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 80,000 | Not disclosed Strike: $18.40 | Not disclosed |
DisclosureSEC source: 0001209191-23-017236 · doc4.xml · derivative · entry 3 Person Julie · CIK 0001946505 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2032-10-24 F1 · kind: The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options. F1 · price: The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options. F3 · derivative.exercise_date: The option vests over a four-year period: 1/48th on November 25, 2022, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 17:01 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | GrantEmployee Stock Option (right to buy) · Derivative | 177,069 | Not disclosed Strike: $4.20 | Not disclosed |
DisclosureSEC source: 0001209191-23-017236 · doc4.xml · derivative · entry 2 Person Julie · CIK 0001946505 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,069 Underlying: Common Stock · 177,069 shares Expires 2032-07-27 F1 · kind: The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options. F1 · price: The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options. F2 · derivative.exercise_date: 25% of the total shares vest on June 20, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 17:01 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 177,069 | Not disclosed Strike: $8.61 | Not disclosed |
DisclosureSEC source: 0001209191-23-017236 · doc4.xml · derivative · entry 1 Person Julie · CIK 0001946505 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 177,069 shares Expires 2032-07-27 F1 · kind: The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options. F1 · price: The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options. F2 · derivative.exercise_date: 25% of the total shares vest on June 20, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 17:00 UTC | Third Harmonic Bio, Inc. THRD · Entity 76517 | GrantEmployee Option Grant (right to buy) · Derivative | 80,000 | $0.00 Strike: $18.40 | $0.00 |
DisclosureSEC source: 0001209191-22-054731 · doc4.xml · derivative · entry 1 Person Julie · CIK 0001946505 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2032-10-24 F1 · derivative.exercise_date: The option vests over a 6-month period: 1/6th on October 25, 2022, after which 1/6th of the total shares vest monthly, subject to continued service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.